研究
2017 研究業績・論文発表
論文
Babaya N, Makutani Y, Noso S, Hiromine Y, Ito H, Taketomo Y, Ueda K, Ushijima H, Komoike Y, Yamazaki Y, Sasano H, Kawabata Y, Ikegami H.
Case report: schwannoma arising from the unilateral adrenal area with bilateral hyperaldosteronism.
BMC Endocr Disord. 2017 Dec 6;17(1):74. doi: 10.1186/s12902-017-0225-z.
Yanae M, Fujimoto S, Tane K, Tanioka M, Fujiwara K, Tsubaki M, Yamazoe Y, Morishima Y, Chiba Y, Takao S, Komoike Y, Tsurutani J, Nakagawa K, Nishida S.
Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acid.
J Bone Oncol. 2017 Aug 31;8:18-22.
Nagashima Y, Yoshino S, Yamamoto S, Maeda N, Azumi T, Komoike Y, Okuno K, Iwasa T, Tsurutani J, Nakagawa K, Masaaki O, Hiroaki N.
Lentinula edodes mycelia extract plus adjuvant chemotherapy for breast cancer patients: Results of a randomized study on host quality of life and immune function improvement.
Mol Clin Oncol. 2017 Sep;7(3):359-366.
Shien T, Tanaka T, Tanabe M, Okumura Y, Masuda N, Yoshida A, Arima N, Komoike Y, Tanaka S, Iwase T, Taguchi T, Nakatsukasa K, Inaji H, Ishitobi M; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.
Evaluation of ALDH1 expression in ipsilateral breast cancer recurrence.
Oncol Lett. 2017 Mar;13(3):1071-1077.
Imoto S, Yamauchi C, Komoike Y, Tsugawa K, Yotsumoto D, Wada N, Ueno T, Oba MS, Shien T, Sugae S, Tsuda H, Yoneyama K.
Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.
Breast Cancer. 2017 May;24(3):427-432.